Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation
- 1 April 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (7) , 707-713
Abstract
The prostanoid, PGE2, is known to inhibit human lung mast cell activity. The aim of the present study was to characterize the EP receptor that mediates this effect. PGE2 (pEC50, 5.8±0.1) inhibited the IgE‐mediated release of histamine from mast cells in a concentration‐dependent manner. Alternative EP receptor agonists were studied. The EP2‐selective agonist, butaprost (pEC50, 5.2±0.2), was an effective inhibitor of mediator release whereas the EP1/EP3 receptor agonist, sulprostone, and the EP1‐selective agonist, 17‐phenyl‐trinor‐PGE2, were ineffective. The DP agonist PGD2, the FP agonist PGF2α, the IP agonist iloprost and the TP agonist U‐46619 were ineffective inhibitors of IgE‐mediated histamine release from mast cells. PGE2 induced a concentration‐dependent increase in intracellular cAMP levels in mast cells. The effects of the EP1/EP2 receptor antagonist, AH6809, and the EP4 receptor antagonist, AH23848, on the PGE2‐mediated inhibition of histamine release were determined. AH6809 (pKB, 5.6±0.1) caused a modest rightward shift in the PGE2 concentration–response curve, whereas AH23848 was ineffective. Long‐term (24 h) incubation of mast cells with either PGE2 or butaprost (EP2 agonist), but not sulprostone (EP1/EP3 agonist), caused a significant reduction in the subsequent ability of PGE2 to inhibit histamine release. Collectively, these data suggest that PGE2 mediates effects on human lung mast cells by interacting with EP2 receptors. British Journal of Pharmacology (2006) 147, 707–713. doi:10.1038/sj.bjp.0706664Keywords
This publication has 41 references indexed in Scilit:
- Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM‐CSFBritish Journal of Pharmacology, 2004
- Role of Cyclooxygenase-1 and -2, Phospholipase C, and Protein Kinase C in Prostaglandin-Mediated GastroprotectionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Characterization of prostanoid receptors mediating inhibition of histamine release from anti‐IgE‐activated rat peritoneal mast cellsBritish Journal of Pharmacology, 2000
- Role of cyclic 3 ́,5 ́-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cellsJournal of Allergy and Clinical Immunology, 1999
- Influence of receptor reserve on β‐adrenoceptor‐mediated responses in human lung mast cellsBritish Journal of Pharmacology, 1998
- Salmeterol inhibition of mediator release from human lung mast cells by β‐adrenoceptor‐dependent and independent mechanismsBritish Journal of Pharmacology, 1998
- Isoforms of the EP3 Subtype of Human Prostaglandin E2 Receptor Transduce Both Intracellular Calcium and cAMP SignalsBiochemistry, 1994
- The mast cell as a primary effector cell in the pathegenesis of asthmaJournal of Allergy and Clinical Immunology, 1986
- Isolation and properties of cardiac and other mast cells from the rat and guinea-pigInflammation Research, 1985
- Mast cell heterogeneityTrends in Pharmacological Sciences, 1983